FIELD: medicine, pharmacy. SUBSTANCE: invention relates to antihyperlipidemic and antihyperproteinemic agents. Agent represents a combination of regulators of energetic metabolism, at least on of that represents succinic acid or its salt, either by the combined using the known antihyperlipidemic agent in combination of some regulators of energetic metabolism or one of that taken in pharmacologically effective doses. Invention provides preparing agent being practically without adverse effects that can be used in treatment of atherosclerosis, ischemic heart disease and obesity. EFFECT: valuable medicinal properties of agent. 15 cl, 5 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENT | 2007 |
|
RU2372923C2 |
AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
AGENT WITH HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTION | 2008 |
|
RU2372897C1 |
AGENT STIMULATING METABOLISM | 1997 |
|
RU2135171C1 |
HYPOLIPIDEMIC PHYTOAGENT | 2013 |
|
RU2553309C2 |
MEANS FOR CORRECTING UROLOGIC ANDROLOGICAL PATHOLOGIES | 2004 |
|
RU2295336C2 |
METHOD FOR PREVENTING AND TREATING ATHEROSCLEROSIS | 1998 |
|
RU2148399C1 |
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
PHARMACEUTICAL COMPOSITION FOR HYPERLIPIDEMIA TREATMENT | 2014 |
|
RU2623876C2 |
Authors
Dates
2004-05-20—Published
2002-11-25—Filed